An engineered genetic circuit for lactose intolerance alleviation

BMC Biol. 2021 Jul 5;19(1):137. doi: 10.1186/s12915-021-01070-9.

Abstract

Background: Lactose malabsorption occurs in around 68% of the world's population, causing lactose intolerance (LI) symptoms, such as abdominal pain, bloating, and diarrhea. To alleviate LI, previous studies have mainly focused on strengthening intestinal β-galactosidase activity while neglecting the inconspicuous drop in the colon pH caused by the fermentation of non-hydrolyzed lactose by the gut microbes. A drop in colon pH will reduce the intestinal β-galactosidase activity and influence intestinal homeostasis.

Results: Here, we synthesized a tri-stable-switch circuit equipped with high β-galactosidase activity and pH rescue ability. This circuit can switch in functionality between the expression of β-galactosidase and expression of L-lactate dehydrogenase in response to an intestinal lactose signal and intestinal pH signal, respectively. We confirmed that the circuit functionality was efficient in bacterial cultures at a range of pH levels, and in preventing a drop in pH and β-galactosidase activity after lactose administration to mice. An impact of the circuit on gut microbiota composition was also indicated.

Conclusions: Due to its ability to flexibly adapt to environmental variation, in particular to stabilize colon pH and maintain β-galactosidase activity after lactose influx, the tri-stable-switch circuit can serve as a promising prototype for the relief of lactose intolerance.

Keywords: Genetic engineering; Gut microbiota; In vitro simulation; In vivo assessment; Lactose intolerance; Synthetic biology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Fermentation
  • Gastrointestinal Microbiome
  • Lactose
  • Lactose Intolerance* / genetics
  • Mice
  • beta-Galactosidase / genetics
  • beta-Galactosidase / metabolism

Substances

  • beta-Galactosidase
  • Lactose